0001209191-20-045075.txt : 20200805 0001209191-20-045075.hdr.sgml : 20200805 20200805160017 ACCESSION NUMBER: 0001209191-20-045075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20200805 DATE AS OF CHANGE: 20200805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de Kruif John CENTRAL INDEX KEY: 0001790353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37773 FILM NUMBER: 201077112 MAIL ADDRESS: STREET 1: C/O MERUS N.V. STREET 2: YALELAAN 62 CITY: UTRECHT STATE: P7 ZIP: 3584 CM ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merus N.V. CENTRAL INDEX KEY: 0001651311 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM BUSINESS PHONE: 31 030 253 8800 MAIL ADDRESS: STREET 1: YALELAAN 62 CITY: 3584 CM UTRECHT STATE: P7 ZIP: 3584 CM FORMER COMPANY: FORMER CONFORMED NAME: Merus B.V. DATE OF NAME CHANGE: 20150819 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-03 0 0001651311 Merus N.V. MRUS 0001790353 de Kruif John C/O MERUS N.V. YALELAAN 62 UTRECHT P7 3584 CM NETHERLANDS 0 1 0 0 SVP & Chief Technology Officer Common Shares 2020-08-03 4 M 0 79 0.00 A 12123 D Restricted Share Unit 2020-08-03 4 M 0 79 D 2020-08-03 Common Shares 79 374 D Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. /s/ Peter Silverman as attorney-in-fact 2020-08-05